Market Cap (In CNY)
5.49 Billion
Revenue (In CNY)
1.81 Billion
Net Income (In CNY)
501 Million
Avg. Volume
2.8 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 21.18-58.5
- PE
- 22.49
- EPS
- 1.01
- Beta Value
- 0.018
- ISIN
- CNE100005XY6
- CUSIP
- -
- CIK
- -
- Shares
- 242169000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Wei Kong
- Employee Count
- -
- Website
- https://www.bchtpharm.com
- Ipo Date
- 2021-06-25
- Details
- Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. Its products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. The company was founded in 2004 and is based in Changchun, China.
More Stocks
-
KIERFKier Group plc
KIERF
-
005930
-
KRROKorro Bio, Inc.
KRRO
-
BDCBelden Inc.
BDC
-
SHJ
-
300331SVG Tech Group Co.,Ltd.
300331
-
TRSTTrustCo Bank Corp NY
TRST
-
ATRO